LOWE BROCKENBROUGH & CO INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
LOWE BROCKENBROUGH & CO INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,624,158
-1.9%
15,945
-2.8%
0.13%
+0.8%
Q2 2023$1,655,832
+7.0%
16,409
-2.5%
0.12%0.0%
Q1 2023$1,547,716
+0.4%
16,823
-1.0%
0.12%
-6.7%
Q4 2022$1,541,424
+19.2%
16,991
-0.1%
0.13%
+7.2%
Q3 2022$1,293,000
-9.1%
17,011
+1.2%
0.12%
+0.8%
Q2 2022$1,422,000
-12.7%
16,817
-9.4%
0.12%
+3.3%
Q1 2022$1,629,000
-6.2%
18,559
-6.5%
0.12%
-5.5%
Q4 2021$1,737,000
+5.8%
19,855
-1.1%
0.13%
-0.8%
Q3 2021$1,642,000
-7.2%
20,079
+3.6%
0.13%
-19.5%
Q2 2021$1,769,000
+7.6%
19,387
+0.8%
0.16%
-0.6%
Q1 2021$1,644,000
-8.8%
19,235
+0.8%
0.16%
-17.9%
Q4 2020$1,802,000
+7.1%
19,078
-1.3%
0.20%
-6.7%
Q3 2020$1,682,000
-4.7%
19,337
-4.3%
0.21%
-11.8%
Q2 2020$1,765,000
+2.1%
20,208
-3.6%
0.24%
-16.8%
Q1 2020$1,729,000
-13.7%
20,968
-0.9%
0.28%
+14.9%
Q4 2019$2,003,000
+8.9%
21,148
-0.1%
0.25%
+0.4%
Q3 2019$1,839,000
-4.5%
21,160
+0.3%
0.25%
-5.7%
Q2 2019$1,926,000
-52.5%
21,098
-50.0%
0.26%
-7.7%
Q1 2019$4,058,000
+128.5%
42,206
+104.0%
0.28%
-2.1%
Q4 2018$1,776,000
+2.8%
20,694
+3.2%
0.29%
+20.3%
Q3 2018$1,727,000
+13.1%
20,049
-0.8%
0.24%
+7.6%
Q2 2018$1,527,000
-8.3%
20,217
-1.9%
0.22%
-8.9%
Q1 2018$1,666,000
-2.4%
20,607
+1.4%
0.25%
+0.4%
Q4 2017$1,707,000
-2.1%
20,329
+0.1%
0.24%
-8.6%
Q3 2017$1,744,000
+1.8%
20,309
-1.0%
0.27%
-0.4%
Q2 2017$1,713,000
+11.2%
20,524
-1.1%
0.27%
+9.3%
Q1 2017$1,541,000
+3.8%
20,754
+1.9%
0.25%
-0.8%
Q4 2016$1,484,000
-1.3%
20,374
+7.0%
0.25%
-4.2%
Q3 2016$1,504,000
-2.7%
19,049
+1.7%
0.26%
-3.7%
Q2 2016$1,545,000
+16.2%
18,724
+2.0%
0.27%
+17.5%
Q1 2016$1,330,000
-10.9%
18,354
+5.8%
0.23%
-10.2%
Q4 2015$1,493,000
-5.7%
17,351
+0.7%
0.26%
-7.9%
Q3 2015$1,584,000
-6.5%
17,2310.0%0.28%
+1.5%
Q2 2015$1,694,000
-0.1%
17,231
+0.2%
0.27%
+2.2%
Q1 2015$1,696,000
+6.7%
17,197
+0.2%
0.27%
+5.5%
Q4 2014$1,590,000
-1.5%
17,1550.0%0.25%
-1.9%
Q3 2014$1,615,000
+2.6%
17,155
-1.4%
0.26%
+2.8%
Q2 2014$1,574,000
+3.1%
17,390
-3.1%
0.25%
-1.2%
Q1 2014$1,526,000
+5.1%
17,946
-0.6%
0.25%
+5.8%
Q4 2013$1,452,000
+4.8%
18,0580.0%0.24%
-4.8%
Q3 2013$1,385,000
+9.2%
18,058
+0.7%
0.25%
+7.2%
Q2 2013$1,268,00017,9330.24%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders